I have a background in physics which has evolved into fields of bio-inorganic chemistry and surface science. This has been motivated by applying physical-chemistry concepts and characterization tools to areas of nanotechnology, biotechnology and pharmaceutical sciences.
These interests are being used to develop improvements in understanding disease, therapeutic delivery and pharmaceutical products and novel methodologies for extracting quantitative metrics in determining relevant parameters. This has been a balance between basic and applied research with interest in clinical developments for human health and engaging pharma industries.
My research has been highly multidisciplinary and incorporated strong collaborations world wide for... Read more
About me
I have a background in physics which has evolved into fields of bio-inorganic chemistry and surface science. This has been motivated by applying physical-chemistry concepts and characterization tools to areas of nanotechnology, biotechnology and pharmaceutical sciences.
These interests are being used to develop improvements in understanding disease, therapeutic delivery and pharmaceutical products and novel methodologies for extracting quantitative metrics in determining relevant parameters. This has been a balance between basic and applied research with interest in clinical developments for human health and engaging pharma industries.
My research has been highly multidisciplinary and incorporated strong collaborations world wide for which I have greatly enjoyed the cultural exchange as well as exposure to exceptional research. I have conducted research in the USA, Canada, Japan, England, The Netherlands, Taiwan and China. I have been the recipient of 5 visiting scholar positions in Canada (the Canadian Light Source and Western University), Taiwan (Institute of Physics, Academia Sinica) and China (Institute of Chemistry, Chinese Academy of Sciences).
I enjoy seeing my research published in high impact journals such as Angewandte Chemie, Small, Chemical Society Reviews, Advanced Materials, the Journal of Controlled Release etc. All up I have over 50 publications including 3 invited book chapters. These are giving rise to rapidly growing citations and an h-index of 19 by PubMed.
Exposure of my work has been given by presentation at over 70 international conference presentations. It is especially recognised by delivering 16 international invited and keynote talks in 8 different countries. The general significance is also demonstrated by being invited twice to represent Australia at the International Atomic Energy Agency (IAEA) technical meetings at the UN headquarters in Vienna, Austria.
Other community duties include:
About me
Doctor of Philosophy University of South Australia
Bachelor of Applied Science University of South Australia
Research
Excludes commercial-in-confidence projects.
Nanoparticle regulation of DNA replication and repair pathways, ARC - Discovery Projects, 21/01/2019 - 20/01/2022
Priming cancer for radiotherapy, Tour de Cure Ltd, 01/01/2020 - 31/12/2020
Nanomedicines Immunotargeting: Hitting the Target or Lost In Translation?, NHMRC - Project Grant, 01/01/2013 - 31/12/2016
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2016 |
|
| 2012 |
1
1
|
| Year | Output |
|---|---|
| 2019 |
58
|
| 2019 |
5
4
6
|
| 2019 |
|
| 2019 |
3
3
2
|
| 2019 |
Open access
|
| 2019 |
|
| 2019 |
2
2
3
|
| 2019 |
|
| 2018 |
2
2
|
| 2018 |
Open access
4
2
|
| 2018 |
Open access
11
9
|
| 2018 |
11
10
5
|
| 2017 |
Open access
5
5
1
|
| 2017 |
Open access
1
2
|
| 2017 |
1
11
|
| 2017 |
Open access
5
5
|
| 2017 |
1
1
|
| 2017 |
Open access
5
3
1
|
| 2016 |
15
15
|
| 2015 |
15
15
|
| 2015 |
Open access
20
21
|
| 2015 |
Open access
46
47
10
|
| 2015 |
7
7
|
| 2014 |
67
79
|
| 2014 |
1
5
|
| 2014 |
18
16
|
| 2014 |
13
16
|
| 2013 |
7
8
|
| 2013 |
9
10
|
| 2013 |
26
26
|
| 2013 |
Open access
12
11
|
| 2013 |
21
19
|
| 2013 |
15
16
1
|
| 2013 |
9
9
|
| 2012 |
18
17
|
| 2012 |
|
| 2012 |
14
14
8
|
| 2012 |
21
17
|
| 2012 |
9
10
|
| 2012 |
28
27
|
| 2011 |
26
28
|
| 2011 |
22
19
|
| 2011 |
Open access
46
41
|
| 2011 |
Open access
60
55
|
| 2011 |
40
41
|
| 2011 |
92
93
3
|
| 2011 |
14
13
|
| 2011 |
102
96
|
| 2011 |
67
62
|
| 2011 |
20
20
|
| 2011 |
25
22
|
| 2011 |
25
18
|
| 2010 |
19
21
|
| 2010 |
55
51
|
| 2010 |
49
47
|
| 2010 |
17
10
|
| 2010 |
Open access
21
16
|
| 2010 |
27
27
|
| 2010 |
13
13
|
| 2010 |
153
152
|
| 2009 |
25
24
|
| 2009 |
16
17
|
| 2009 |
52
47
|
| 2008 |
30
28
|
| 2008 |
39
36
|
Research
External engagement & recognition
| Organisation | Country |
|---|---|
| Academia Sinica | TAIWAN |
| Argonne National Laboratory | UNITED STATES |
| Australian Synchrotron Company Ltd | AUSTRALIA |
| Brookhaven National Laboratory | UNITED STATES |
| Chang Gung University of Science and Technology | TAIWAN |
| China Medical University | TAIWAN |
| Chinese Academy of Sciences | CHINA |
| Chung Yuan Christian University | TAIWAN |
| City University of Hong Kong | HONG KONG |
| Commonwealth Department of the Environment and Water Resources | AUSTRALIA |
| CSIRO Australia (Commonwealth Scientific Industrial Research Organisation) | AUSTRALIA |
| Dana-Farber Cancer Institute | UNITED STATES |
| Ecole Polytechnique | FRANCE |
| Ecole Polytechnique Federale de Lausanne | ITALY |
| Fermiscan Holdings Ltd. | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Hefei University of Technology | CHINA |
| Institute of Medical and Veterinary Science | AUSTRALIA |
| Kaohsiung Medical University | TAIWAN |
| Lincoln University | NEW ZEALAND |
| Mackay Memorial Hospital | CHINA |
| Museum of Victoria | AUSTRALIA |
| National Center for High-Performance Computing | TAIWAN |
| National Cheng Kung University | TAIWAN |
| National Chiayi University | TAIWAN |
| National Chung Hsing University | TAIWAN |
| National Defense Medical Center | TAIWAN |
| National Health Research Institute | CHINA |
| National Health Research Institutes | TAIWAN |
| National Sun Yat-Sen University | TAIWAN |
| National Synchrotron Radiation Research Centre | TAIWAN |
| National Synchrotron Radiation Research Centre (NSSRC) | TAIWAN |
| National Taiwan Ocean University | TAIWAN |
| National Taiwan University | TAIWAN |
| National Taiwan University College of Medicine | TAIWAN |
| National Taiwan University Hospital | TAIWAN |
| National Tsing Hua University | TAIWAN |
| National University of Singapore | SINGAPORE |
| National Yunlin University of Science and Technology | TAIWAN |
| pSiMedica Ltd | UNITED KINGDOM |
| Queensland University of Technology | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| Southeast University | CHINA |
| Sun Yat-Sen University | CHINA |
| Swiss Federal Institute of Technology Lausanne | SWITZERLAND |
| Tatung University | TAIWAN |
| Tunghai University | TAIWAN |
| Université Paris-Saclay | FRANCE |
| University College London | UNITED KINGDOM |
| University of Adelaide | AUSTRALIA |
| University of Bordeaux | FRANCE |
| University of Notre Dame United States | UNITED STATES |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| University of Tasmania | AUSTRALIA |
| University of Technology Sydney | AUSTRALIA |
| University of Western Ontario | CANADA |
| US Environmental Protection Agency | UNITED STATES |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
MemberAmerican Chemical Society (ACS) |
2018 |
Certificate in Recognition of Work (First ever foreign recipient)Supreme Public Prosecutors Office, Taiwan |
2017 |
MemberAmerican Chemical Society (ACS) |
2017 |
Keynote SpeakerWorld Congress on Medical Physics and Biomedical Engineering |
2015 |
Keynote Speaker16th International Workshop on Radiation Imaging Detectors, Italy |
2014 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Development of nanomedicines for the radiosensitization of proton beam therapy | Current |
| Exploring the hair follicles as targets to improve the effectiveness of antidandruff therapies | Current |
| Nanotechnology for inhibiting cellular DNA damage repair | Current |
| Stochastic modelling of gold nanoparticle enhancement of dose and reactive species yield for proton therapy | Current |
| Structure-function relationships in nanoparticle genotoxiticty | Current |
| The role of metal nanoparticles and the metal core/metal oxinde shell structure when utilised as radiosensitisers in X-ray radiation therapy | Current |
| Tumour cell population heterogeneity: Therapeutic challenges and opportunities | Current |
| Fundamental understanding, development and industrial applications of copper binding glutaraldehyde-polyethyleneimine coatings: antifouling, remediation, and sensing | Completed |
| Radiosensitization of cell sub-populations by gold nanoparticles: cross-correlative microscopy for elucidating fundamental mechanisms | Completed |